We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vernalis | LSE:VER | London | Ordinary Share | GB00B3Y5L754 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.17 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
29/9/2016 07:31 | Moxatag looks like dead duck. | fhmktg | |
28/9/2016 11:25 | First indication of Tuzistra performance tomorrow, could be crucial to the long term prospects for Vernalis. | fhmktg | |
09/9/2016 13:14 | also has dropped below the director's purchase price of £0.45 now (see header) | bountyhunter | |
05/8/2016 08:43 | I'm surprised the share price hasn't responded more positively, given that most of the sales for new products will be in dollars.Let's hope the summer cough and cold market has been booming in the US. | fhmktg | |
26/7/2016 13:42 | Buying continues! | fhmktg | |
26/7/2016 13:18 | Vote of continued support from Woodford! | fhmktg | |
14/7/2016 12:59 | Looks like we may have bottomed out folks. | investordave | |
13/7/2016 16:21 | I saw this as having some confidence that either the current supplier site would continue or a deal to transfer the site of manufacture, which would take some deal with the FDAEither way some market feedback as to how receptive the key prescribers are could help? | fhmktg | |
13/7/2016 15:34 | fhmktg I see the following 19 May 2016 The following lines are worrying: Whilst the launch of Moxatag(R) will still occur this summer, the uncertainty over further supply will impact Vernalis' additional promotion of Moxatag(R). I believe we are in the summer and the company should be telling us what is happening in relation to supplies. 19 May 2016 LSE: VER Moxatag Supply Update Vernalis plc ("Vernalis" or the "Company") was informed yesterday that Suir Pharma Limited ("Suir") of Clonmel Ireland, the sole source supplier of finished dosage form Moxatag(R), has been placed into Provisional Liquidation. Information is limited at this time, but the liquidator has indicated that it intends to seek a purchaser for the business as a going concern. Suir has already supplied launch stocks of Moxatag(R) to Vernalis, which are currently stored at Vernalis' third party warehouse in the US and are available for supply to wholesaler customers. The timing of further supplies is now uncertain as Suir is currently the only approved supplier under the Moxatag(R) NDA. Whilst the launch of Moxatag(R) will still occur this summer, the uncertainty over further supply will impact Vernalis' additional promotion of Moxatag(R). This additional promotion will now occur when there is more certainty over the timing of routine ongoing supply. This will not have a material impact on our financial position or our trading results for the financial years ending 30 June 2016 and 2017. The Company expects to provide a further update on publication of its financial results for the year ended 30 June 2016. - Ends - | twodegrees | |
12/7/2016 17:21 | See the May 19th RNS. | fhmktg | |
12/7/2016 16:50 | fhmktg, surely the company should be giving us an update on what is going on. | twodegrees | |
11/7/2016 09:00 | Could be possible to move Moxatag to Saneca the Suir previous owner over a time period, given they have all the data on the product but would need FDA approval. Could be expedited with commitment from both parties. | fhmktg | |
08/7/2016 11:10 | September for news on the supply chain I believe? | fhmktg | |
08/7/2016 10:14 | fhmktg, this was recovering very well in fact had hit new highs and has been walked all the way back down because of possible supply issues. I am annoyed that the company has not given any indication yet if the supply chain has been sorted and that has contributed to a share price fall of over 505 in 4 months...so I tend to disagree that progress is being made. I f we have a product and cannot get it to market...then ???????? | twodegrees | |
08/7/2016 08:13 | Slow but steady progress towards a new company, but it's a 4-5 year timeframe.Not sure how the share price will evolve.Any thoughts or predictions? | fhmktg | |
09/6/2016 16:24 | well spotted, now in the header - I'll tidy it up later | bountyhunter | |
09/6/2016 16:16 | director buys x 2 and it falls...woops | twodegrees | |
09/6/2016 16:04 | Good sign when ceo and cfo buy shares, underpins confidence! | fhmktg | |
20/5/2016 18:22 | Beat me to it, thinking the same thing...So why? | ffp | |
20/5/2016 15:29 | with all the money that vernalis raised why don't they buy it | twodegrees |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions